← Open Payments lookup

ANNA HOUSMAN: Open Payments

NPI 1609161694 · BRISTOL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,861 in 71 payments from 19 companies in 2025. Trend: 2023 $1,221 · 2024 $1,619 · 2025 $1,861

Food & beverage: $1,861
CompanyPaymentsAmount
Madrigal Pharmaceuticals8$429
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$200
Ardelyx, Inc.10$198
Aimmune Therapeutics, Inc.6$189
Takeda Pharmaceuticals U.S.A., Inc.6$169
ABBVIE INC.7$141
Lilly USA, LLC3$76
Intercept Pharmaceuticals, Inc.3$71
GENZYME CORPORATION2$53
Phathom Pharmaceuticals, Inc.4$51

Products named: REZDIFFRA, IBSRELA, ZENPEP, XIFAXAN, ENTYVIO, OMVOH, OCALIVA, RINVOQ.

Industry payments across CT — which companies pay providers there.